Devdatt Kurdikar

Devdatt (Dev) Kurdikar serves as the President and Chief Executive Officer of embecta since April 2022, a leading diabetes care company focused on innovative insulin delivery solutions. Kurdikar's extensive experience includes board memberships with Zimmer Biomet, AdvaMed, and LMG Holdings Inc., along with a prior role as President of Diabetes Care at BD, which established embecta as a standalone entity. Previous leadership positions encompass President and CEO of Cardiac Science, General Manager at Boston Scientific, and Senior Vice President at American Medical Systems. Academic qualifications include a PhD in Chemical Engineering from Purdue University and an MBA from Washington University in St. Louis.